Current Controversies and Future Prospects for Peanut Allergy Prevention, Diagnosis and Therapies

A dual-functional paper-based analytical device for ultrasensitive detection of peanut allergen-specific IgE

BACKGROUND

Increasing attention has been caught by the allergy-related food safety issue. The rapid and sensitive diagnosing approaches are still in high demand for providing clinical reference. Paper-based analytical devices (PADs) are appealing candidates for allergy diagnosis and prediction due to their portability, stability, and operational easiness. However, the sensitivity of PADs needs to be further improved for the targets with low abundance. In addition to the complex signal amplifications, an alternative strategy that requires fewer reagents, steps, and shorter time is anticipated. (82) RESULTS: We report fluorescent PADs (FPADs) that can accumulate and detect the major peanut allergen glycoprotein Arachis hypogaea h2 (Ara h2)-specific IgE (sIgE). The FPADs are constructed by in-situ synthesis of blue-emissive carbon dots (BCDs) on the surface of cellulose paper, followed by the conjugation of Ara h2. After the capture of sIgE, a green-emissive carbon dots-labeled secondary anti-sIgE reporter (Ab2-GCDs) is assembled on FPADs. The detection relies on the sIgE concentration-dependent color variation of FPADs. In addition, the accumulation of sIgE is achievable by filtering the sample through FPADs, improving the assay sensitivity and efficiency. It is demonstrated that the limit of detection (LOD) is 15.7 ng/mL, evidently lower than the simple immersion-based assay (90.2 ng/mL). The excellent selectivity allows sIgE quantification in serum with high accuracy. (130) SIGNIFICANCE: By harnessing the outperforming sensing performance of the proposed FPADs, the rapid, accurate, and cost-efficient diagnosis and prediction of peanut allergy can be realized. In addition, the FPADs could serve as a universal sensing platform for varying targets by flexibly engineering the capture moieties on the surface of fluorescent paper. (50).

Establishment of DAS-ELISA and lateral flow immunochromatography for the detection of peanut allergen Ara h 3 after heat-moisture treatment

Peanuts are highly nutritious but pose a significant risk of triggering food allergies. While heat treatment can reduce the allergenicity of many foods, it may also alter their structure, potentially impacting detection results. This study employed double antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA) and lateral flow immunochromatography (LFIA) to evaluate the allergen Ara h 3 following heat-moisture treatment. DAS-ELISA achieved a detection limit of 39.06 ng/mL, with inter-plate and intra-plate coefficients of variation below 3.05 % and 6.79 %, respectively, and recovery rates ranging from 78.48 % to 90.93 %. LFIA, with a detection limit of 1.6 μg/mL, demonstrated high sensitivity, stability, and no cross-reactivity with other proteins. Both methods were effective in detecting peanut-processed products, with heat-moisture treatment significantly reducing Ara h 3 antigenicity, making them valuable tools for assessing desensitization in food production.

Characteristic features of food allergy to legumes: From epidemiology to prevention

INTRODUCTION

The study aims to investigate the main characteristics of food allergies to legumes (peanuts, chickpeas, soybeans, lentils, beans, and peas).

MATERIALS AND METHODS

A search was conducted for relevant information in the ResearchGate, PubMed, Scopus, Google Scholar, and Web of Science databases, presented for 2011-2024.

RESULTS

The study determined that about 30 % of the world's population has allergic diseases. Of them, 10 % were diagnosed with food allergies. In Poland, the prevalence of this pathology is about 5 %. The epidemiology of food allergies to peanuts is 2-5 %. The prevalence of sensitisation to lentils is 5-7 %; to beans - 7.5 %; to soybeans - 9-10.4 %; to peas - 9.5 % and to chickpeas - 8.5 %. At the same time, no food allergies to soy have been detected in adults in Poland. Peanuts are the most allergenic food among those described in this study, as they have a high risk of sensitisation to nuts and legumes (soybeans, lupins, peas, chickpeas, lentils). The clinical picture of a legume allergy is characterised by hives, itching, sneezing, redness, lacrimation, nausea, vomiting, wheezing, angioedema, and anaphylactic shock. For the diagnosis of food allergy to legumes, an oral test, prick test, determination of the level of allergen-specific immunoglobulin E (IgE), and basophil activation test are used. Emergency care is provided using an epinephrine solution at a dosage of 1 mg/ml intramuscularly. Immunotherapy with allergens is used to treat delayed-type hypersensitivity reactions. To prevent legume allergy, physical, chemical, and biological methods of treatment and individual nutrition are used.

CONCLUSIONS

The study concluded that food allergy to legumes is a common pathology that contributes to the development of severe complications and requires detailed study.

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed anaphylaxis in foods containing the oligosaccharide galactose-α-1,3-galactose (α-Gal) such as mammalian meat or dairy products. Clinical presentation of AGS can also comprise immediate hypersensitivity due to anticancer therapy, gelatin-containing vaccines or mammalian serum-based antivenom. The IgE initial sensitization is caused by hard-bodied tick bites and symptomatic individuals typically develop delayed pruritus, urticaria, angioedema, anaphylaxis, malaise or gut-related symptoms. Due to inapparent presentation, delayed reactions and a wide variety of patients´ clinical history, the AGS diagnosis and treatment remain challenging. This review covers not only current diagnostic methods used for AGS such as the skin prick test (SPT), the oral food challenge (OFC), anti-α-Gal IgE levels measurement and the basophil activation test (BAT), but also potentially relevant next-generation diagnostic tools like the mast cell activation test (MAT), the histamine-release (HR) assay, omics technologies and model-based reasoning (MBR). Moreover, it focuses on the therapeutical medical and non-medical methods available and current research methods that are being applied in order to elucidate the molecular, physiological and immune mechanisms underlying this allergic disorder. Lastly, future treatment and preventive tools are also discussed, being of utmost importance for the identification of tick salivary molecules, with or without α-Gal modifications, that trigger IgE sensitivity as they could be the key for further vaccine development. Bearing in mind climate change, the tick-host paradigm will shift towards an increasing number of AGS cases in new regions worldwide, which will pose new challenges for clinicians in the future.

High-dimensional immune profiles correlate with phenotypes of peanut allergy during food-allergic reactions

BACKGROUND

Food challenges carry a burden of safety, effort and resources. Clinical reactivity and presentation, such as thresholds and symptoms, are considered challenging to predict ex vivo.

AIMS

To identify changes of peripheral immune signatures during oral food challenges (OFC) that correlate with the clinical outcome in patients with peanut allergy (PA).

METHODS

Children with a positive (OFC⁺ , n = 16) or a negative (OFC^- , n = 10) OFC-outcome were included (controls, n = 7). Single-cell mass cytometry/unsupervised analysis allowed unbiased immunophenotyping during OFC.

RESULTS

Peripheral immune profiles correlated with OFC outcome. OFC⁺ -profiles revealed mainly decreased Th2 cells, memory Treg and activated NK cells, which had an increased homing marker expression signifying immune cell migration into effector tissues along with symptom onset. OFC^- -profiles had also signs of ongoing inflammation, but with a signature of a controlled response, lacking homing marker expression and featuring a concomitant increase of Th2-shifted CD4⁺ T cells and Treg cells. Low versus high threshold reactivity-groups had differential frequencies of intermediate monocytes and myeloid dendritic cells at baseline. Low threshold was associated with increased CD8⁺ T cells and reduced memory cells (central memory [CM] CD4⁺ [Th2] T cells, CM CD8⁺ T cells, Treg). Immune signatures also discriminated patients with preferential skin versus gastrointestinal symptoms, whereby skin signs correlated with increased expression of CCR4, a molecule enabling skin trafficking, on various immune cell types.

CONCLUSION

We showed that peripheral immune signatures reflected dynamics of clinical outcome during OFC with peanut. Those immune alterations hold promise as a basis for predictive OFC biomarker discovery to monitor disease outcome and therapy of PA.

Chemical Authentication of Botanical Ingredients: A Review of Commercial Herbal Products

Chemical methods are the most important and widely used traditional plant identification techniques recommended by national and international pharmacopoeias. We have reviewed the successful use of different chemical methods for the botanical authentication of 2,386 commercial herbal products, sold in 37 countries spread over six continents. The majority of the analyzed products were reported to be authentic (73%) but more than a quarter proved to be adulterated (27%). At a national level, the number of products and the adulteration proportions varied very widely. Yet, the adulteration reported for the four countries, from which more than 100 commercial products were purchased and their botanical ingredients chemically authenticated, was 37% (United Kingdom), 31% (Italy), 27% (United States), and 21% (China). Simple or hyphenated chemical analytical techniques have identified the total absence of labeled botanical ingredients, substitution with closely related or unrelated species, the use of biological filler material, and the hidden presence of regulated, forbidden or allergenic species. Additionally, affecting the safety and efficacy of the commercial herbal products, other low quality aspects were reported: considerable variability of the labeled metabolic profile and/or phytochemical content, significant product-to-product variation of botanical ingredients or even between batches by the same manufacturer, and misleading quality and quantity label claims. Choosing an appropriate chemical technique can be the only possibility for assessing the botanical authenticity of samples which have lost their diagnostic microscopic characteristics or were processed so that DNA cannot be adequately recovered.

Novel diagnostic techniques and therapeutic strategies for IgE-mediated food allergy

Background: Immunoglobulin E (IgE) mediated food allergy is a potentially life-threatening condition and represents a heavy burden for patients and their families. Identification of the most suitable way for management of each patient has currently become the primary goal for physicians. Methods: This study reviewed the current literature related to IgE-mediated food allergy. Results: The use of innovative diagnostic tools, such as allergen-specific IgG4 determination, basophil activation test, and component-resolved diagnostics, is currently available to facilitate a proper diagnosis of food allergy. After several decades of "passive clinical management" of the disease, which was based only on avoidance of the allergenic food and the use of epinephrine in the event of anaphylaxis, there has been a switch to active treatment. The most recent evidence-practice guidelines strongly recommend the use of immunotherapy as an effective therapeutic option, particularly in cases of allergy to cow's milk, egg, or peanut. The use of omalizumab, in association with immunotherapy or alone, has been tested in several studies, and results on its effectiveness seemed to be encouraging. Other biologics, such as dupilumab, reslizumab, mepolizumab, and other anticytokines therapies, are being investigated. Another interesting future treatment strategy could be the use of DNA vaccines. Conclusion: In recent years, the management of IgE-mediated food allergy has greatly improved. Knowledge of pathogenetic mechanisms, understanding of the disease course, and the introduction of novel biomarkers led to more accurate diagnoses along with the active treatment of patients.

Oral immunotherapy for treatment of peanut allergy

The US Food and Drug Administration's approval of a peanut oral immunotherapy product in January 2020 is a landmark development in the field of food allergy therapy. While food allergy prevalence has been increasing, this product is the first approved therapy for food allergy. Oral immunotherapy has many similarities to subcutaneous immunotherapy and drug desensitization protocols, but does not lead to sustained unresponsiveness. The studies leading to approval of the Palforzia product demonstrated increase in the amount of peanut protein able to be consumed, with 67% of subjects randomized to the treatment arm able to consume 600 mg of peanut protein in double-blind placebo-controlled food challenge at study exit. However, side effects are an important consideration, and dropout rates in studies of Palforzia ranged from 11% to 21%. Postmarketing surveillance of this product will be critical in assessing its long-term risks and benefits.